Class IIIReported 2025-10-22

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

Recalled by STAQ Pharma, Inc.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Recall Number

D-0023-2026

Classification

Class III

Status

Ongoing

Category

drug

Initiated

2025-10-09

Reported

2025-10-22

Distribution

Nationwide in the U.S.

Code Info

Lot #: 25104595A, Expiry: 27DEC2025.

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.